Thousands of microorganisms compose the human gut microbiota, fighting pathogens in
infectious diseases and inhibiting or inducing inflammation in different immunological …

According to outcomes from clinical studies, an intricate relationship occurs between the
beneficial microbiota, gut homeostasis, and the host's health status. Numerous studies have …

Aside from centrally induced trained immunity in the bone marrow (BM) and peripheral
blood by parenteral vaccination or infection, evidence indicates that mucosal-resident innate …

Although tuberculosis (TB) is a curable disease, it remains the foremost cause of death from
a single pathogen. Globally, approximately 1.6 million people died of TB in 2017. Many …

Trillions of beneficial and hostile microorganisms live in the human respiratory and
gastrointestinal tracts, which act as gatekeepers in maintaining human health, ie, protecting …

Despite compartmentalization within the lumen of the gastrointestinal tract, the gut
microbiota has a far-reaching influence on immune cell development and function …

Tuberculosis (TB) remains an infectious disease of global significance and a leading cause
of death in low-and middle-income countries. Significant effort has been directed towards …

Chronic Obstructive Pulmonary Disease (COPD) has significantly contributed to global
mortality, with three million deaths reported annually. This impact is expected to increase …

Tuberculosis (TB), caused by Mycobacterium tuberculosis attacking the lungs and other
organs, is one of the most common infectious disease worldwide. According to the WHO's …

Increasingly, gut microbiota distortions are being implicated in the pathogenesis of several
infectious and noninfectious diseases. Specifically, in the absence of an eubiotic microbiota …